Skip to main content
. 2004 Dec;48(12):4766–4777. doi: 10.1128/AAC.48.12.4766-4777.2004

FIG. 2.

FIG. 2.

Predicted garenoxacin concentrations versus observed garenoxacin concentrations (A), weighted residuals versus predicted garenoxacin concentrations (B), weighted residuals versus the time since administration of the last dose (C), and individual predicted garenoxacin concentrations versus observed garenoxacin concentrations (D) for the final model (n = 1,529).